Employees Retirement System of Texas’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
EAM
ACG
JMFC
Employees Retirement System of Texas's DNA Position: Q4 2025 in Review
Employees Retirement System of Texas sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 5,432 shares — an estimated $79K sold.
Employees Retirement System of Texas first reported a position in DNA in Q4 2023 and held it in 8 quarters. The position peaked at $252K in Q1 2024. 180 funds tracked by Wall St. Rank hold DNA as of Q4 2025.
- Employees Retirement System of Texas reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
- Employees Retirement System of Texas sold 5,432 Ginkgo Bioworks shares in Q4 2025, an estimated $79K.
- Employees Retirement System of Texas first reported a position in Ginkgo Bioworks in Q4 2023 and held it in 8 quarters.
- Employees Retirement System of Texas's Ginkgo Bioworks position peaked at $252K in Q1 2024.
- 180 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.
Based on Employees Retirement System of Texas's 13F filing for Q4 2025, filed 9 Feb 2026.